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Those who attended this year's alumni reunion were treated to a preview
of the new Library and Biomedical Communications Center.
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Newsbriefs
Scans aid breast cancer tberallY

P

hysicJ<UlS may one day
rely on picture:- 
rarher than ~urgery - lO
individ ually tailor treatmenl\
for palients who have breast
cance r.
cienti ts al the School o t
Medicine have crealed the first
images of human breast lumors
llsing pos ilron emis\ion tomog
mph} (PET). Breast c-anct:r can
be imageJ with mammugraphy
and other ratliologic tech
nique~. but lhe advantage of
PET is that it may e nable doc-

crop up at other site~ in the
body. The work has bee n re
poned in the journal Radiol
ogy. and will be presented at
thl:: nalional meeting o f the
Society of Nuclear Medicine,
held this past June in
St. Lou i'
The research team - headed
by mdiation chem ist M ichael
J. Welch . Ph .D" profess or of
radio log -created pictures of
the cancer that existed in the
breasts of 13 women, using
PET to scan eSlrogen receptors

The detection ofestrogen receptors in these primary and meta
static breast tumors prol'idits evidence that estrogen-receptor all
tagonists may be an effective treatment for this patient.
tors to detel1n inc -without
biopsies-which tumors wil l
re~pond to hommne therapy
and to monitor, almost im
medi ately, the effect i ve ne~s of
that treatment
Tlle"e findi ngs are expected
[0 be especially lmportant in
treatjng metastatic breal>t
cancer. a fom) of brea~l cancer
in wh ich the primary tumor
spreads. and secondary tumors
2

concentmted in their Lumors.
The ability to produce those
hi g h-resol ution images re pre
),ents a sweeping advance in
the fi eltl .
' This is the firs t lime a
lu mor receptor has hee n
imaged in humans," Welc h
says . "The impact could be
tremendous :.
In order to use PET success
fully, Welch and his colleagues

first had to devise a highly
specific radioactive tracer, a
derivative of natural estrogen
called F-18 fl uoroestradiol.
The drug. when injected into a
woman 's body, binds to the
estrogen receptors in her
system.
W hen tracked on a PET
scanner, it reveals the concen
tration of those estrogen recep
tors in any tumors, producing
actual images of the cancer.
T he PET scientists confif/l1ed
the ir work by comparing their
PET-based calculations of
estrogen receptor levels to
measurements obtained during
subsequent biopsies: good
conelation was obtained .
The concentration of estro
gen receptors is what
determines a breast tumor's
response to treatment. Hormon
al therapy. preferred by most
doctors because of its rela
tively harmless side effects, is
effective almost two-thirds of
the time when estrogen recep
tor levels are high enough.
Knowing the nature of the
tumor would allow doctors to
prescribe hormonal therapy
with a reasonable assurance of
its effectiveness, and with a
second scan, to quickly check
treatment progress and make
adjustments if necessary. Not
knowing, they must wait for
the hOf/l1onal therapy to regis
ter its effectiveness, meaning
they risk wasting months of
potentially valuable treatment
time.
Estrogen-receptor imaging
could make a crucial difference
in treatment for patients with
metastatic cancer. Welc h says.
Biopsies can provide infof/l1a
ti on about primary tumors, but
the PET technique is the only
means available for learning
about secondary tumors
those that occur in the sur
rounding bones, mu scles and

lymph nodes, and that spread
rapidly to other parts of the
body.
" It '$ the secondary tumors
that kill people;' he says . ' The
success or failure of therapy
depend s on the receptor status
of the secondary tumor, not the
primary tumor. The primary
tumor can have gobs of recep
tors, but if the secondary has
none, the therapy wi II not
work ."
" B reast cancer's not like
strep throat, where you know
the treatment will work if the
diagnosis is correct ;' explains
oncologist Alan P Lyss, M.D. ,
who has refened numerous pa
tients to Welch's study. "When
the disease is cancer, the per
centages are more variable
the certainty is not as great.
And we can ' t afford to waste
precious time with ineffective
treatment."

New McDollllell
Scholar arrives
rie c. Beyer. M.D.,
will serve as the
School of Medicine's
first McDonnell Scholar in
Cancer Research .
Beyer, who joined the fac
uity July I, recently was
named a 1989 McDonnell
Scholar by the James S.
McDonnell Foundation's Pro
gram for Molecular Medicine
in Cancer Researc h. His
appointment brings with it a
three-year, $375,000 grant
that will enable him to pursue
his research in oncology.
The McDonnell Founda
tion's program was established
thi s year to develop physician
investigators who will apply
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techniques of modem biology
to problems in clinical oncol
ogy. It supports young physi
cians who have demonstrated
superior potential for original
basic research as well as an in
terest or training in oncology.
Beyer's work focuses on
molecules on ceJl surfaces that
are involved in cellular com
munication, adhesion and
development. Using the
techniques of molecular and
cellular biology, he has isolated
membrane proteins that fonn
tunnel-like structures between
cells. The ~e "gap junctions"
playa role in passing between
cells small molecules involved
in metabolic support , grow th
control and the development
of embryos . In the heart. they
permit electrical communica
tion from one muscle cell to
another. Beyer pl ans to study
the synthesis and assembly of
the gap junction proteins and to
analyze their role in cell-to-cell
communication in normal and
cancer cells .
Before coming to
Washington Unive rsity. Beyer
was an instructor of pediatrics
at Harvard Medi cal School. He
also served as an ass istant in
medicine at The Children's
Hospital and as a clinical asso
ciate at the Dana Farber Can
cer Institute. Since 1985, he
was a research fellow at The
Children's Hospital. the Farber
Cancer Institute. and the
departments of pediatrics and
anatomy and cellular biology at
Harvard Medical School.
Beyer received his doctorate
in physiology and pharmacol
ogy in 1981 and his medical
degree in 1982 from the
University of Cal ifornia in San
Diego. He has received numer
ous awards and honors for his
research , including the 1987
American Heart Association's
Clinician Scientist Award. •

Drs. BarziJai (left) alld Lappas obtain better
resvlrlliQII of heart tissue when sound w(JI'e.\· lire

Echot."ardio~rapl1f·r8
chool of Medicine
physicians are lIsing a
new fom1 of echocard i
ography, called transesophagea l
echocardiography, to monitor
patients du ri ng open-heart
surgery and to di a gno~e heart
problems that otherw ise
would be difficult to see
with traditional thoracic
echocard iography.
Both techn iques prod uce
images of heart function by
bouncing sound waves off
heart tissues. But instead of
delivering sound waves from a
transducer placed on top of
the chest-as is the case in
thoracic echocard iography
transesophageal cchocard i
ography del ivers sound waves
from a tube inserted into the
throat.
Because the esophagus lies
directly behind the left allium
of the heart. placing the trans
ducer down the esophagus
yi elds a better picture than
placing il on the chest. accord
ing to Drs . Lappas and
Barzilai, who have been u ~i ng
th is new technique for about
a year.
Thoracic echocardiography
falls short of the theorct ical
resolution that would be ex
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directed from a tube tllm is imerled ;lIlo/he
throat tllan whell directed through the chest.

take it clo~er to the heart

peeted hecause the lung . ribs
and chest wall block the quality
of the image, says De metrios
G. Lappa,'" M ,D . professor of
anesthesiology. Also, the high
frequency waves needed for ll1e
best rc~ ol ut ion cannot be used.
because they would be ab
sorbed by the chest wall .
"There's a law of physics that
stale ~ that the higher the fre
quency. the higher the attenua
tion (absorption);' say" car
diologist Benico Barzilai.
M.D , a<;sistant professor of
medicine . "To penetrate the
chest wall and go through all
that mu rJ...y terrain , you need a
lower frequency."
Bal7 il ai likens thof'dcic
echocard iography to the view
of the person who sits in the
back row of a lecture hall. To
see the speaker. he has 10 look
thro ugh a crowd of people.
lta nsesophageal echocmdi
ogmphy. on the other hand . i~
like ~ ilting on stage behind the
speaker.
One obvious drawback to
the esophageal metl10d is that
it involves the insertion of a
tube down the throat. This i ~
~ lig h tl y invasive and requires a
mild sedati ve and a drug to
num b the throat .

Yet the advantages of the
new technique far outweigh
the inconvenience ant.! discom
fort . according to Lappas and
Burtilai . Intraoperative use of
boll1 methods has found trans
esophageal echocardiography
to be better at detecting clots in
the chambers of the heart,
localing damaged valves and
as~ess ing the pumping action
of the ventricul ar chambers.
according to Lappas. who ha~
evaluated the use of t.J'3ns
esophageal echocardiography
in more than 200 patients.
Barzilai adds that the esoph
ageal technique is a more
sensitive and accurate method
of assessing the condition of
artificial valves after surgical
re placement .
The School of Metiic.:ine was
one of the first institutions in
the Midwest to usc the trans
esophageal method of echocar
diography. Barzilai e ~tima les
lhat about 5 percent of all
echocard iographies perfonned
here are now done with this
technique . He and Lappas are
continuing to eval uate the
useful ness of the technique
through studies that com
pare it with thomc ic
echocardiography. •
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New psychiatry
department head
Robert Cloninger,
M.D., a scientist
• who is recognized
worldwide for studies on the
inheritance and classification
of psychiatric disorders, has
become the new head of the
Department of Psyc hiatry at
the School of Medicine . He is
also the new psychiatrist-in
chief at Barnes Hospital .
Cloninger replaces Samuel
B. Guze, M.D., who has
served as head of the depaJ1
ment since 1975.
Cloninger is perhaps best
known for his work on the
clinical assessment of per
sonality and his adoption
studies in Sweden. This work
allowed him in 1981 to identify
two types of alcoholism: with
type 1, the most prevalent ,
drinking begins in the mid-20s
to 30s, causes medical prob
lems in later years, and is the
result of both genetics and en
vironment; with type 2, which
usually occurs in men and
often in criminals, inherited
tendencies are the primary
cause and there are rarely
medical problems.
Cloninger also has studied
the classification and inherit
ance of many other psychiatric
disorders, including schizo
phrenia , anxiety disorders ,
mood disorders and personality
disorders. He is working with
colleagues on molecular ge
netic research to locate linkage
markers, the specific genetic
mechanisms related to suscep
tibility to alcoholism and
schizophrenia.
Cloninger received his medi
cal degree from Washington
University in 1970, then spent
three more years at the medical
school as an assistant resident
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and a National Institute of
Mental Health (NIMH) assis
tant and trainee in psychiatry.
He joined the Washington
University faculty in 1973 as
an instructor in psychiatry.
From 1975-85, Cloninger
conducted stud ies as an NIMH
research scientist development
awardee in quantitative ge
netics. During that period, he
spent a year as a visiting inves
tigator at the University of
Hawaii's Population Genetics
Laboratory.
Cloninger was named asso
ciate professor of psychiatry in
1978 and of genetics in 1979,
becoming a full professor in
both departments in 198 1. In
addition, he has served as
visiting professor of psychiatry
and genetics at the University
of Umei'! School of Medicine
in Umei'!, Sweden.

C. Robert Cloninger, M.D.
Cloninger is a diplomate of
the American Board of Psy
chiatry and Neurology and a
fellow of the American Psychi
atric Association and the
American Psychopathological
Association. He is associate
editor of the journal Genetic
Epidemiology and an editorial
board member of the Archives
of General Psychiatry.

Olson advises on hmnan genome
aynard Y. Olson,
Ph.D ., professor of
genetics at the School
of Medic ine , has been chosen
as one of 12 members of the
National In stitutes of Health's
Program Advisory Committee
on the Human Genome .
The corrunittee will adv ise
the NIH and its associate direc
tor for human genome re
search , Nobel Prize-winning
scientist James D . Watson ,
Ph .D., on the new NIH initia
tive to map and sequence the
human genome. Watson and
his colleague Francis Crick
won the Nobel Prize in 1962
for their di scovery of the
molecular structure of DNA.
Olson is associate director
of the university's Center for
Genetics in Medicine. He is
renowned for his innovative
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method of cloning human
DNA in yeast celis, a tech
nique that allows larger unique
fragments of human DNA to
be cloned and puri fied than
was previously possible. His
work plays a significant role in
the effort to piece together the
human genetic puzzle by map
ping and sequencing the entire
human genetic structure.
Scientists think that doing so
could lead to the determination
of the genetic basi s for as
many as 3,500 diseases caused
by genetic mutation, as well as
possible ways to diagnose, cor
rect and prevent many genetic
disorders.
Olson will serve a four-year
term on the corrunittee, which
includes members from acade
mia , industry and non-profit
organizations. The goals of the

Cloninger has received an
honorary doctor of medicine
degree from the University of
Umei'! for distinguished contri
butions to genetic epidemi
ology of psychiatric disorders ,
and the 1988 Strecker Award
from the Institute of Pennsyl
vania Hospital for sign ificant
contributions to psychiatric pa
tient care and treatment. •

committee include the training
of scientists, the coordination
of the program with private
sector resources, the manage
ment of the massive data
processing and storage
requirements that will be nec
essary to handle the knowledge
gained through the program,
and the consideration of ethical
and legal issues that may arise.
It is estimated that the total
cost of the human genome ini
tiative could be $3 billion over
the next 20 years. President
George Bush has allocated
$100 million to the NIH in fis
cal year 1990 for this project.
Olson came to the School of
Medicine in 1979 as an assis
tant professor of genetics , and
was named professor in 1987.
He received his doctorate in
chemistry from Stanford
University in 1969. •

Study looks at drug use and AIDS
inda CottJer, Ph.D., an
epidemiologist in the
Department of Psy
chiatry, has received funding
to conduct the first study in
the St. Louis area on the
prevalence of Hrv infection
in intravenous drug users and
their needle-sharing and sexual
partners.
A research instructor, Cottier
will receive a total of $797 ,000
from the National Institute on
Drug Abuse for the project.
Until now, there have been
no studies in St. Louis to de
termine the prevalence of HIV
infection in drug users, Cottier
says, because of the area's rela
tively low number of reported
AIDS cases. However, research
and educational efforts else
where in the country have be
gun to focus on IV drug users ,
she notes, since educational
programs have stabilized the
rate of new HIV infections
among homosexuals.

L

The St. Louis study will
follow some 650 subjects,
including 300 IV drug users ,
150 non-IV drug users and
200 sex partners. In addition to
studying prevalence of HIV
infection, Cottier will evaluate
risk factors for HIV infection
particularly the co-occurrence
of psychiatric symptoms,
other substance abuse, needle
sharing, personality and high
risk sexual behaviors-to
better target public education
efforts.
Ultimately she hopes to de
termine whether education can
help change high-risk be
haviors and thus reduce the in
cidence of HlV infection in
this study population.
Participants for Cottier's
project will include prisoners
and prostitutes, as well as
clients in area drug treatment
programs. Sexual partners
will be recruited as well. •

Lipid researcher studies proteins
that carry cholesterol and fat
he director of the
School of Medicine's
Lipid Research Center
has been awarded a $1.1 mil
lion grant to study the role of
certain blood proteins in caus
ing atherosclerosis.
The National Institutes of
Health grant was awarded to
Gustav Schonfeld , M. D .,
Kountz Professor of Medicine
in the Department of
Medicine .
The grant will support a
project titled "Metabolism of
Genetic Variants of Apolipo
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protein B." The study will
involve looking for variants
of the blood protein that are
responsible for carrying
cholesterol and triglycerides,
with a goal of finding the
structure-function relationships
of apoB and its role in
atherosc lerosis.
In addition to directing the
Lipid Research Center, Schon
feld is head of the metabolism
division at Jewish Hospital and
on staff at Bames Hospital.
A 1956 graduate of
WaShington University and a

j
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These tracings of tadpole blood vessel development were made
on three consecutive days.
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Inside the "visible tadpole"
arl Rovainen, Ph .D.,
has a new window on
blood vessel develop
ment, a phenomenon believed
to playa critical role in tumor
formation, eye damage in dia
betics, vascular malformations
in the brain , wound healing ,
arthritis and skin diseases such
as psoriasis and sc leroderma.
A professor of cell biology
and physiology, Rovainen
views the growth of blood ves
sels through the transparent
skin of albino tadpoles, which
he injects with a flourescent
dye while they are still
embryos.
As they grow, he maps the
developing spiderweb-like ves
sels and studies how various
physical and chemical factors
affect this development.
Knowing more about normal
blood vessel development,
Rovainen says, may eventually

C

help scientists to understand
what goes wrong in cases of
abnormal blood vessel growth,
and provide ways to regulate
this growth.
Blood vessel growth is key
to many physiological pro
cesses and diseases. The rapid
growth and spread of tumors ,
for example, is sustained and
nourished by blood vessels. In
vading capillaries are thought
to cause cartilage destruction in
arthritics and hemorrhaging in
the eyes of diabetics. Blood
vessel growth heals wounds
and , when malformations re
sult, may lead to rupture of
aneurysms and stroke.
Rovainen is currently map
ping the normal growth of
blood vessels in albino tad
poles. He then plans to test the
effects of various growth fac
tors on this development. •

1960 graduate of the School of
Medicine , he joined the faculty
in 1968 as an assistant profes
sor of medicine . He became a
full professor in 1977 and was
named Kountz professor in

Society for Clinical Investiga
tion, the American Society of
Biological Chemists and the
Council on Atherosclerosis,
American Heart Association.
He also is associate editor of
the journal Circulation. •

1987.
Schonfeld belongs to many
professional societies, includ
ing the Association of Ameri
can Physicians, the American

.'
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Stu ent Stage
ltlalchUay 1989
"

tOLaI of 99 Wa~hington
University medical
students partic ipated
in this year's National Resi
dency Match ing Program.
Sixty percent of these stu
dents matched with tbei r first
choice. while 87 percent
matched with one of their top
three choices .
Surgery. obsteu'ics and gyne
cology, pediatrics , and anes
thesiology laimetl a greater
porti n of School of Medicine
grad uates than last year. First
year appo in t men~ for the class
of 1989 are a~ follows:

A

California
L Of/1£I Linda
Loma Linda Univcl ity
Char! s S. Lee, General
_·urgery. Otolaryngology
L()/lK Beach
Sl. Mary -' Medi~al Center

ayyer Z. Ali . lnternal
Med icine
Los Al1ge{(!!,

UCLA Medical Center
ArLhur J. Moser. General
Surgery
LA County-USC McdiL'U1
Center
Melvin H. 11 oroton,
Ob~tetric~ & Gynecology
Sail Diego
.S. aval Hospital
Elizabeth T. McKi nney.
Obstetri ~ & Gynecology

San Francisco
University of California, San
Francisco
Michon Morita, Surgery
Preliminary, eurological
Surgery
Stanford
Stanford nivers iry Hospital
Davi d J. Loftus. Internal
Medicine
Jonathan R. Perry. eneral
Su rgery
Torrance
Harbor-UCLA Medical Center
atherine A. Han lon, Internal
Medicine
Holly E. Perry, Pediatrics
7i'avis AFB
USAF Medical Center
Susan L. Sward. Pedi atrics

Palll Rvhio/io (left) and Richard Strauss draw their f utures f rom the stage.
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Colorado
Denver
University of Colorado School
of Medicine
John B . Ebens, Internal
Medicine
Thomas R . MacKenzie,
Internal Medicine
Connecticut
New Haven
Yale-New Haven Hospital
Michael Apkon , Pediatrics
Tommy W. Chu Pediatrics
Mark J. Shepard . Orthopedic
Surgery

Flurida
Gainesville
niversity of Florida Medical
Center
Robert P. Quarles, Diagnos tic
Radiology

Illinois
Chicago

University of Chicago Medical
Center
Miriam T. Schteingart,
Internal Medicine
Preliminary, University of
Illinois, Ophthalmology
Michael Reese Hospital
Mark Silverberg,
Anesthesiology
Iowa
Jmva City

University of Iowa Hospitals &
Clinics
Robert G. Jacoby, Internal
Medicine, Neurology
Steven O. Podolsky,
Obstetrics & Gynecology
Barbara Rohland, Psychiatry
Timothy C. Samelson,
Pediatrics
Kansas
Kansas City

University of Kansas School of
Medicine
Daniel C. Roney, Family
Practice
Louisiana
New Orleans

Tulane University School of
Medicine
Susan M. Berkebile ,
Obstetrics & Gynecology
Michael W. Carpenter,
General Surgery
Mary Lee Cherry, Obstetrics
& Gynecology
Maryland
Baltimore

Francis Scott Key Medical
Center
Jeany Tung, Internal
Medicine, Johns Hopkins
Hospital, Anesthesiology
Johns Hopkins Hospital
Chandlee C. Dickey,
Psychiatry

Joost and Gail Knops fi nd their spots 011 the Match Day lisr.

Massachusetts

Minnesota

Boston

Minneapolis

Beth Israel Hospital
Nancy K, Cho, General
Surgery
Brigham & Women 's Hospital
Paul A, RobioJio, Internal
Medicine
Faulkner Hospital
Martin S, Arkin, Internal
Medicine Preliminary,
Massachusetts Eye & Ear
Hospital. Ophthalmology
Massachusetts General
Hospital
Ellen M, Reynolds, General
Surgery

University of Minnesota
Hospitals
S. Kathi Doster. Surgery
Preliminary. Neurological
Surgery

Cambridge

Massachusetts Institute
Technology
Scott Selleck, Postdoctoral
Fellow, Department of Brain
& Cognitive Science

Rochester

Mayo Graduate School of
Medic ine
Matthew G , Cary, Internal
Medicine
Gail L. Knops, Fami ly
Practice
Joost L Knops.
OtOlaryngology
Mississippi
Biloxi

USAF Hospital , Kee~ l er AFB
Daniel T. Kane. GenemJ
Surgery
Matthew B. Krebs. Geneml
Surgery

Michigan

Jackson

Royal Oak

University Hosp ital
Jacqueline G, White. General
Surgery

William Beaumont Hospital
Brent C. Thompson,
Diagnostic Radiology

Missouri
Columhia
Univer;ity of Mi~S0uri
Timothy L. Bartholow,
Family Practice
Willi am Y. Walker, Internal
Medicine
St. LOllis
Barnes Hospital
Kelly M Ask.ins . Psychialry
'red J. Ba l i~. Internal
Medicine
Gregory 0 , Cohen. Interna l
Medicine
Elisa A, Crouse-Amos.
Ohsteuics & Gynccology
Laura E. Dyer. Internal
Medicine Preliminary
Michelle R. De Vera.
Obstt'tri c~ & Gynecology
Nun B. Farber. Psychiatry
Phyll is L Faust. Anatomic
Pathology
Brett R. Fink. Surgery
Preliminary
Gabriela Adelt Green .
Anatomic Pathology
Dan iel G. Hafenrichter.
General SW'gery
7

Peggy P. Klebba , Obstetrics
& Gynecology
Patry Lee, Otolaryngology
Gregory W. Mattingly,
Psychiatry
Douglas A. Nemecek.
Psyc hiatry
Steven D. Rettinger, General
Surgery
Anita L. Swrunerfield,
Anatomic Pathology
Patlick T. Tong, Internal
Medicine Preliminary,
Washington Universiry,
Special Study,
Ophthalmology
Dwight A. Towler, Internal
Medicine
Gregory P. Watchmak.er,
General Surgery
Edward C. Wong, Laboratory
Medicine

Mark S. Zobel, Diagnostic
Radiology
Jewish Hospital
C. Michael Crowder, Internal
Medicine Preliminary,
Universiry of Washington
Affiliated Hospital, Seattle,
Washington, Anesthesiology
Randall L. Goskowicz.
Internal Medicine
Preliminary, University of
California, San Diego.
L. A., Anesthesiology
Jeffrey W. Hoffmeister.
Radiology
John M. Holland, Internal
Medicine Preliminary
Norton C. Lin, Internal
Medicine Preliminary,
Harbor-UCLA Medical
Center, Torrance , CA. ,
Anesthesiology

Robert M. McMahon.
Internal Medicine
Preliminary
Doris F Nussenbaum,
Internal Medicine
Carol Olmstead. Internal
Medicine
Mark Rich, Internal Medicine
Preliminary, Johns Hopkins
Universiry, Baltimore, MD.,
Neurology
David E. Schleinkofer,
Internal Medicine
Raghujit Singh , Internal
Medicine
Rebecca S. Walker, Internal
Medici ne Preliminary,
Washington Universiry,
St. Louis, MO.,
Ophthalmology
Heidi K. White , Internal
Medicine

St. Louis Children's Hospital
Patrick S. Clyne, Pediatrics
Robert C. Fuhlbrigge,
Pediatrics
Ronald M. Grady, Pediatrics
Jacalyn W. Hazen. Pediatrics
Allison L. Hernandez ,
Pediatrics
Jonathan W. Mink. Pediatrics
Forbes D. Porter, Ped iatrics
John J. Puetz. Pediatri cs
David A. Sweetser, Pediatri cs
Jeffrey H. Teckman,
Pediatrics
New York
New York
New York Medical College
Bryan J. O ' Young, Phy.
Medicine & Rehabilitation

From left to right: Gilbert Rigaud, Michon Morita and Nayyer Ali exchange news of their first-year appointments.
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Rochester
Strong Memorial Hospital
David T. Harvey, Internal
Medicine Preliminary
Felice A. Heller, Pediatrics
Michael P. Steinberg, Internal
Medicine
Richard C. Paul, Surgery
Preliminary, Urology
Stony Brook
Stony Brook Teaching
Hospitals
Kermeth R. Lidonnici,
Pathology

North Carolina
Chapel Hill
North Carolina Memorial
Hospital
B. Todd Granger, Internal
Medicine
Durham
Duke University Medical
Center
Rodney 1. Folz , Internal
Medicine
Howard J. II ivicky, Psychiatry
Winston-Salem
North Carolina Baptist
Hospital
Janel A. Cox, Internal
Medicine Preliminary,
Bowman Gray School of
Medicine , Radiation
Oncology
T. David Cox, Diagnostic
Radiology

Ohio
Cleveland
University Hospital of
Cleveland
William C. Schroer, Surgery
Preliminary

Oklahoma
OklaJwma City
University of Oklahoma
College of Medicine
Jeffrey D. Dixon , Emergency
Medicine

Oregon
Portland
Oregon Health Sciences
University
John T. Berger, Pediatrics

Rebecca Walter (left) and Peggy Klebba seem happy with their maJches.

Pennsylvania

Tennessee

Ph iladelph ia
Temple University
John C. Fang, Internal
Medicine
Hospital of the University of
Permsylvania
Steven C. Schmidt, Surgery
Preliminary
Children's Hospital
Richard S. Strauss, Pediatrics
Pittsburgh
Mercy Hospital
Kevin D. Clark, Transitional,
East Virginia Medical
School , Norfolk, VA.,
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A leadership of integrity, balance and fairness
BY MARION HL"·r

D ressed in their new white coats,
the third-year medical students
had planned to present a psychiat
ric inpatient to Samuel B.
Guze, M.D., Spencer T. Olin Pro
fessor and Head ofthe Depart
ment ofPsychiatry. They were un
derstandably nervous; and to
make matters worse, the patient in
question decided to leave the hos
pital against medical advice. This
could have made the two hours al
lottedfor teaching rounds longer
than usual. Instead, Guze turned
the session into a compelling dis
cussion ofthe ethical dilemma in
volved in involuntary commitment.
"Twenty years ago," he said, "it
would have been easyfor a psy
chiatrist concerned about his pa
tient's welfare to commit him to the
hospital against his wiU. Because
ofchanges in the law, this is no
longer true. Nevertheless, I believe
the grounds for commitment
should lWt be the narrowest ones
ofpotential suicide or harm to
others. When judgment is im
paired by mental iUness, patients
can do a great deal ofdamage to
their lives and their families."
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"~I always wanted to be a doctor;'

Samuel Guze, M.D., as a young resident.

Drawing on his long clinical ex
perience, Guze then presented the
students with a patient ofhis own,
an impaired physician who had
resisted treatment, and asked
them how they would have han
dled the situation. There were no
easy answers in either case, but a
master teacher had illustrated the
dilemma ofinvoluntary commit
ment in a way these medical stu
dents would notforget.

says Guze, 44 years after he graduated from
Washington University School of Medicine .
During his long and distinguished career,
which he began here in 1945 as an intern in
medicine, Guze has fulfilled this ambition
in a multitude of ways . Although his first
choice upon graduating in 1945 was to train
in internal medicine , by 1950 he had made
the unusual switch to psychiatry. His goal,
as he remembers explaining it to Drs. Barry
Wood and Carl Moore-his chiefs in the
Department of Medicine-was to transfer
the rigor of internal medicine to the field of
psychiatry.
Because he had the good fortune to be at
the right medical school at the right time,
Guze was able to fulfill this hope . He
helped to lay the basis for a new biological
approach to psychiatry and was appointed
head of the department in 1975. Guze
entered the administration of the medical
school as assistant to the dean in 1965; he
was named vice chancellor for medical af
fairs in 1971 . His retirement from adminis
tration this year has therefore meant step
ping down from two important positions
that of vice chancellor on March 1 and that
of department head on July 1. Guze's satis
faction with the work he has done in both
positions is expressed in the relish with
which he discusses it. But he is obviously
happy to give up administration to devote
full-time to research, teaching and patient
care.

Colleagues keenly appreciate the con
tributions he has made both to the school
and to his specialty. Chancellor William
Danforth (who preceded him in the vice
chancellor's position) said, "Institution
building is something that I value highly.
The Washington University School of
Medicine and the medical center have pros
pered under Sam's leadership. I know of no
institution in the country that has advanced
further or more rapidly, and I doubt if there
is a medical center or medical school in the
country better prepared for the future ...
Sam has set an example for all of us by
conducting himself with integrity, balance
and fairness."
His partner in leading the school for the
last 18 years, Dean M. Kenton King, com
mented: "I have known Sam for 32 years.
He has always been a star in every facet of
our endeavors: an excellent teacher, a su
perb clinician, a very good researcher and
an extraordinary administrator. I want to
emphasize that he was a leader in medical
school affairs long before he became vice
chancellor or head of psychiatry: he was
responsible for a major curriculum change
in 1969."
His longtime deputy in the vice
chancellor's office, Virginia Weldon,
M. D., now vice president for public affairs
at Monsanto , said, "The School of Medi
cine has changed profoundly under Sam
Guze's leadership. It has become a much
larger, more complex organization. This is,
in part, due to rapid changes in the external
environment, but it is also due to the em
phasis Sam has put on maintaining this
school as a leading research institution."
Statistics offer convincing evidence of
how the school has prospered during the 18
years he served as vice chancellor. The
budget when Guze took this position in
1971 was $34,000,000; it is now in excess
of $300,000 ,000. The number of endowed
professorships has increased from 15 to 36.
The number of employees has doubled.
Full-time faculty has increased from 475 to
869; part-time faculty from 260 to 981.
Square feet owned by the school have in
creased from 1,385,916 to 2,292,784
including the Clinical Sciences Research
Building. which was the last major addition
of space. But the size of the medical center
is only one indication of its health. Its influ
ence can be measured in other ways as well
- by the number of medical students who
have themselves become researchers and by
the essential medical care graduates provide
across the country.
In addition to overseeing this tremendous
expansion. Guze 's contributions to psy
chiatry have been significant. He has writ
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ten or collaborated on 175 scientific papers.
While fulfilling administrative duties as de
partment head and vice-chanceUor, he con
tinued important research. In 1972, he and
co-authors Drs. Donald Goodwin and
Robert Woodruff wrote a text on psychiatric
diagnosis. Now in its fourth edition, it is
considered a classic in the field.
Goodwin, now chairman of the depart
ment of psychiatry at the University of
Kansas , says: "Sam produced first-rate sci
entific articles even when he was holding

Dr. Guze leads a discussion with third
year medical students on professors'
rounds.

two jobs. He has contributed to a remark
able change in values and practices of
American psychiatry in the I 960s and
1970s. Together with Eli Robins (Renard
Professor in the Department of Psychiatry)
and George Winokur (now chairman at the
University of Iowa School of Medicine), he
instilled a spirit of scientific inquiry into a
new generation of psychiatrists-a number
of whom now hold chairs in important
universities ... He is certainly among the
clearest thinkers I have ever known."
Guze is a leading figure in what has be
come known as the "Washington University
School of Psychiatry." It is an approach
with a strong alliance to biology and a
medical view of mental illness. Relying on
empirical data, its practitioners seek to clar
ify and validate diagnoses - insisting that
facts rather than theories should guide their
conclusions. As Goodwin wrote in the pref
ace to the first edition of "Psychiatric Diag
nosis;' "This approach to psychiatry ... is
sometimes called 'organic.' This is mislead
ing. A better term ... is agnostic. Without
evidence. we do not believe pills are better
than words. Without evidence, we do not

believe chemistry is more important than
upbringing. Without evidence, we withhold
jUdgment."
Conclusive evidence that this school of
thought had become influential came with
the publication of the "American Psychiat
ric Association's DSM III" (Diagnostic and
Statistic Manual of Mental Disorders, third
edition) in 1980. Its becoming an immedi
ate best seller when previous books of this
kind had very little influence indicated an
important change in the way psychiatrists
thought about mental illness. To quote from
Goodwin and Guze's 1988 preface to the
fourth edition of "Psychiatric Diagnosis":
"Sixteen years have passed since this book
was first published. In that time an interest
ing change has occurred in American
psychiatry. Psychiatrists have become
diagnosis-conscious ... with the discovery
of relatively specific drug therapies, diag
nosis had become practical ... people
actually stood up at meetings and asked:
'Where is the evidence?' These were real
changes. We like to think 'Psychiatric
Diagnosis' anticipated them."
The truth of this statement is clear.
Washington University-trained psychiatrists
made up a third of the DSM III task force,
the largest contingent from any single
school. The department here had been de
veloping scientifically based diagnostic
categories long before 1980. In an article
titled 'The Need for Toughmindedness in
Psychiatric Thinking;' published in 1970,
Guze answered potential criticisms to this
approach: "Scientific skepticism is in no
way incompatible with compassion for the
sick. In fact , it is the desire to heJp patients
that causes one to be frustrated by the lack
of definite knowledge about what really
helps and what does not." Distinguishing
one treatment from the other has occupied a
major portion of Guze's professional life.
The tradition of biologically oriented
psychiatry had begun at Washington
University during Edwin Gildea's tenure as
chairman of the department from 1942 to
1963. He encouraged biochemical and
pharmacological studies of the brain at a
time when the influence of Freudian theory
in American psychiatric circles was
supreme and largely unquestioned. His
open-mindedness attracted bright young in
vestigators to his department , among them
Robins, who succeeded Gildea as chairman
in 1963. Robins' research strengthened and
extended the biological approach to psy
chiatry. Drs. Robins, Winokur and Guze
formed a formidable trio of agnostic psy
chiatrists, and developed the precepts and
practices of what became known as the
"Washington University Schoo!." Demon

strable and reproducible facts, rather than
theories, were the key to their approach. In
addition to biochemistry and pharmacology,
long-term family and follow-up studies
became crucial research tools. Thus, when
Guze became department head in 1975, he
inherited a position with a tradition of
excellence in research.
Guze's intellectual promise was evident
early in his academic career. Born in New
York City, he attended the accelerated three
year course at Townsend Harris High
School and graduated at the age of 15 in
1939. Next, he entered City College for
two-and-a-half years before transferring for
a final year at Washington University; he
graduated in 1942 and entered the School
of Medicine. World War II meant that this,
too, was an accelerated course of study, and
Guze obtained his medical degree in June
1945 at the age of 21.
He took an internship and residency in
internal medicine at Barnes Hospital , fol
lowed by another year at a Yale-affliated
veteran's hospital in Connecticut, before re
turning to St. Louis as the medical center's
first fellow in psychosomatic medicine .
What he learned during this fellowship
was vital to his later decision to enter psy
chiatry: that patients with obscure illnesses
could be helped if a doctor approached
them with a practical and open-minded
point of view. So much did he enjoy this
experience , that he decided to make the
commitment to psychiatry. As Guze re
members, he said to himself: "If I have to
become a psychiatrist in order to do what I
enjoy, okay." In addition to the extra work a
second fellowship entailed, he was taking a
considerable risk by switching to psychiatry
at a time when it lacked the rigor, discipline
and status of internal medicine .
Robins played a partiCUlarly important
role in encouraging Guze's hopes for psy
chiatry. "What Eli did was to open up for
me the literature in the tradition of his
mentor, Dr. Mandel Cohen-a British and
European literature in psychiatry that
showed it was possible to make psychiatry
a data-based (instead of theoretical) spe
cialty." In 1955, Guze became director of
the psychiatry clinic and consultant to
the student health service at WaShington
University. " It was;' he remembers , "an
important symbolic step" - indicating a
final professional commitment to
psychiatry.
Together, Guze, Robins and Winokur
divided responsibilities and created a de
partment with a strong commitment to
research and training based on fact rather
than theory. As he recalls, "Because we
were mavericks, we attracted unusual

The Guzes enjoy a stroll through the rose garden at the Missouri Botanical Garden, one
oftheir favorite places to visit.
people to our program." One problem was
obtaining research funding at a time
when Freudian theory reigned supreme.
However, within a few years of Robins '
taking over as chairman of the depart
ment, the fruitfulness of their research find
ings helped tum the tide in favor of the
Washington University approach to
psychiatry - federal grants began to come
their way.
When Guze took over the vice
chancellorshi p from Danforth in 1971, he
found in place a strong foundation on which
to base his work. A new relationship with
Barnes Hospital was already thriving.
Much of what he has done in the last 18
years, he believes , has been adding to what
Danforth had established in terms of
healthy institutional relations . But there
were new problems where he was able to
make his own particular contribution-one
of these has been the redevelopment pro
gram, started to improve and protect the
neighborhoods around the School of Medi
cine. Richard A. Roloff, president of the
Plaza Development Company, says, "Sam
Guze has been the key to the success of the
redevelopment program. His persistence,
keen intellect, patience and sense of justice
made him the perfect choice for the leader
ship role he has played as president of the
Redevelopment Corporation."
Guze gives enormous credit to Dean
King for the pleasure he 's had in his job as
vice chancellor. They have been partners in
steering the medical school's course for
nearly two decades . "It's been a ball;' he
says. "Ken's great virtues are fairness ,
integrity and open-mindedness. Even if we
didn't agree, one or the other of us would
compromise-and we could always talk.
We met twice a week for 24 years to talk

about the School of Medicine , and it was a
joy."
Guze looks forward to his retirement
years with keen anticipation. He plans to
spend more time with his wife, Joy, and his
two children and four grandchildren. But he
will certainly continue being active in
teaching, patient care, research and writing.
The final comments about Guze's career
at Washington University are best taken
from his own writing. In a 1979 article
titled "Can the Practice of Medicine be Fun
for a Lifetime?" (published in the Journal
of the American Medical Association)
Guze wrote, "If the physician can view his
practice as offering an almost infinite range
of interesting problems, it is less likely that
boredom and frustration will triumph . . .
The best of education is self-education. The
goal of teachers can never be higher than to
help begin the lifelong process of continu
ing self-education and thus share in count
less harvests."
During his career, Guze has indeed
explored "an almost infinite range of inter
esting problems;' and there 's no doubt that
he will continue to do so in his busy retire
ment. A leading medical educator has lik
ened handing over administrative control of
a medical center to relinquishing the reins
of a horse at full gallop. The velocity of this
institution's growth owes much to Guze's
leadership. But it will not be slowed by the
necessary transition his retirement requires .
'The transfer of institutional memory" is
the phrase Guze has used to describe the
briefings he gave William Peck , M .D.,
who succeeded him as vice chancellor on
March 1. Guze's years of work as scholar
and administrator are certainly a distin
guished part of that memory.
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he research of Ray E. Clouse, M.D .,
has led him into what is perhaps the
stickiest philosophical problem of all
time : the relationship between mind and
body.
A gastroenterologist and assistant profes
sor of medicine at the School of Medicine,
Clouse has been investigating the sneaking
suspicion-held by layman and physician
alike-that depression, worry or a bad day
at the office are the invisible hands that
wrench a patient's gut, resulting in a variety
of gastrointestinal (GI) illnesses.
Clouse has fOlll1d that people who suffer
from initable bowel syndrome and esopha
geal spasms, functional diseases with no
identifiable pathology, have more emotional
disorders than other physically ill people or
people in good health. Patients with these
GI problems also seem to improve with the
help of antidepressant medications. But
then comes the caveat: the antidepressants
appear to help nondepressed and depressed
patients alike .
Such ambiguous results characterize the
research Clouse and others at the School of
Medicine are conducting on the link be
tween physical disease and emotions. It's a
murky field made even murkier by unsub

stantiated claims of the New Age move
ment - heal your body with mental images
-and the attitudes of physicians toward pa
tients afflicted in both body and mind. One
attitude takes the form of blame: "Your dis
ease is psychosomatic, so improve your
state of mind." The other attitude is benign
neglect: "If I had heart disease, I'd be de
pressed, too. It's a normal reaction."
Shining their lights into this quagmire,
the medical school researchers are debunk
ing a few myths as well as discovering some
likely connections between how we feel and
how our bodies function . Rather than lung
ing toward some unified theory for the in
teraction of physical disease and emotion,
these physicians and psychologists are
slowly building a body of evidence.
In the process, they are coming up with
possible treatments for diseases they still
don't understand in full. Perhaps just as im
portant, the research is encouraging physi
cians to approach the emotional problems
of their patients in more constructive ways.
Clouse says the psychosomatic issue
presses itself upon physicians whether they
like it or not. After all, people with physical
illnesses are more likely to suffer from psy
chiatric illnesses than the population at

large . Statistics on clinical depression, the
most widespread major psychiatric illness ,
illustrate this point. Depression occurs in
20 percent to 25 percent of the physically
ill, but just three percent to four percent of
the total popUlation, says Clouse.
"The problem is, doctors want to treat GI
disorders. But when they ask their patients
how they are doing , all they hear about are
their personal problems;' says Clouse. "If
they had wanted to deal with emotional
problems , they would have gone into
psychiatry:'
Clouse's jump into the psychiatric end of
GI disorders wasn ' t without some trepida
tion. The subject didn't enjoy a good repu
tation in medical circles.
"Research on ulcerative colitis did the
most damage to the study of the relation
ship between emotion and disease . At one
time, it was believed to be psychosomatic.
Later research showed that it wasn't."
One 1982 study originating from the
School of Medicine , for instance, indicated
that lifetime psychiatric illness is no more
common in ulcerative colitis patients than
in other chronically ill subjects .
Another medical school study, however,
came to a different conclusion about
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Ray Clouse, M.D.

Crohn's disease, an inflammation of the in
testines that can cause diarrhea, abdominal
pain and fatigue. Of 50 patients with
Crohn's disease , 52 percent had some form
of psychiatric illness , higher than the per
centage for a medically ill control group.
However, the onsets of the GI and psychiat
ric disorders were unrelated, and the sever
ity of one illness did not parallel the severity
of another. Such evidence did not exactly
constitute a smoking gun on the psychoso
matic nature of Crohn's disease.
Clouse and others discovered a similarly
high rate of psychiatric illness among pa
tients with irritable bowel syndrome emS)
and esophagael spasms. Separate studies on
each GI disorder showed that over half the
patients taking antidepressants reported im
proved symptoms. In the case of IDS pa
tients taking a tricylcic antidepressant, 89
percent experienced relief or complete
remission. But why did the drugs work
regardless of whether the patient felt less
depressed?
Tho possible explanations involve the
role of the autonomic nervous system in
governing the digestive organs.
"The bowels, for instance, don't depend
on the brain for most movement:' says
Clouse. "The majority of the fibers between
the brain and bowels are sensory, not motor
in nature. They monitor bowel functions.
" Most nerve bodies for the bowels are in
the bowels. It's like a mini-computer with
preprogrammed activities."
The origins of IDS and esophageal
spasms may reside in these nerve bodies
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outside the brain , says Clouse. Antidepres
sants may accidentally affect the bowel
nerve bodies as well as the control centers
in the brain for the emotions.
The two GI diseases also could have
their roots in brain centers that mostly
monitor and modulate the GI system. Evi
dence suggests these centers might overlap
or border those governing the emotions ,
says Clouse. An antidepressant aimed at
emotion centers might affect GI control
centers as well.
A third explanation for the apparent effi
cacy of antidepressants is that, contrary to
his initial studies, these drugs indeed pro
duce an emotional change that in tum influ
ences the GI system . In his experiments,
Clouse used dosages lower than what a
psychiatrist would prescribe. His studies in
dicated that patients experienced relief from
IBS and esophageal spasms without im
proving psychologically, but Clouse says
different psychological measures might
yield other conclusions.
atrick J. Lustman, Ph .D., an assistant
professor of medical psychology in
psychiatry, who collaborated with
Clouse on the drug experiment with
esophageal-spasm patients, has teamed up
with Clouse and others to examine depres
sion and diabetes. One study, headed by
Lustman, found that 23 percent of diabetics
suffered from current depression , while
almost 33 percent had a major depressive
episode sometime in their life. Depressed
diabetics reported more symptoms of poor
blood-sugar control such as sweating, fre
quent urination and hunger than nonde
pressed diabetics.
Depression also appears to take a more
malevolent course among diabetics than
others, he says, but the two diseases other
wise progress independently. Depressed
diabetics do not necessarily develop more
complications, nor do they become more
depressed when complications occur.
To Lustman, these findings represent
associations of fact, not cause and effect.
The explanation could be behavioral.
"It could be that when you're depressed,
you don't take care of yourself. Or if you 're
depressed, you may complain more."
But Lustman has not ruled out a biologi
cal connection . After ali, the bloodstreams
of depressed people have abnormally high
levels of insulin antagonists as well as cor
tisol, a hormone that may in tum raise glu
cose levels. Conversely, elevated glucose
levels can produce a stress-like hormonal
arousal observed in severe anxiety.
To test the glucose link, Lustman and

Janet B. McGill, M.D., instructor in medi
cine and pediatrics, have begun giving ther
apeutic dosages of psychoactive drugs to
diabetics with sharply fluctuating blood
sugar levels. A group of anxious diabetics
receives an anti-anxiety drug, a depressed
group receives an antidepressant and a
healthy group receives both. Control groups
in each category receive placebos. Lustman
and McGill will look at whether glucose
control improves in any or all of the groups,
and whether it improves without remission
of psychiatric symptoms.
Unlike depression, stress does not seem
to have any special relationship to diabetes,
says Lustman.
"Stress is hard to measure. Divorce, for
instance, means one thing to one person
and something entirely different to another
person. Some people are crushed, while
some people are very optimistic.
"Depression tends to be a reliable, identi
fiable syndrome. Our physicians respond
better to that diagnosis. When we say,
'Your patient is depressed: they under
stand. It's not the day-to-day blahs. It's a
clinical syndrome that impacts a person's
quality of life and impairs their ability to
function.
"If we say ' He's under stress: they say,
'Who isn ' t?'"
Stress is overstressed, according to
Clouse.
"All this attention to stress reduction cer
tainly hasn ' t reduced the number of people
seeking care for these GI problems. The
numbers for the functional disorders are
actually on the incline."

Patrick Lustman, Ph.D.

sychologist Robert M . Carney, Ph .D . ,
an associate professor of medical psy
chology in psychiatry, is searching for a
possible physiological relationship between
depression and coronary artery disease
(CAD). It's more than a wild hunch. Ac
cording to a recent study headed by Carney,
17 percent of patients with CAD were cl in
ically depressed before the CAD diagnosis.
Within a year of the diagnosis, the de
pressed patients had twice as many cardiac
crises-heart attack, surgery or death
than their nondepressed counterparts.
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Robert Carney, Ph.D.

The study stated that the cases of clinical
depression do not "appear to simply be a
reflection of severity of disease, degree of
functional impainnent, presence of other
disease processes, cardiac medications or
abnormalities of ventricular function."
While depression may not be a root
cause, says Carney, "r think it can
accelerate CAD:'
Like Lustman, Carney says there may be
a behavioral explanation. Depressed CAD
patients may become less healthy because
their illness distrupts living patterns such as
sleep, or because they take less care of
themselves. Also, they may complain
more, leading their physicians to take more
drastic actions like coronary bypass surgery.
''I'm betting, however, that the link has
to do with ischemia-deprivation of oxy
gen to the heart;' says Carney. Again, it's
not a shot in the dark. Depression triggers
an increase of neurotransmitters called cate
cholamines, associated with arteriosclerosis

in animal studies. Catecholamines also can
cause arteries to constrict and blood plate
lets to stick together. Each effect could con
tribute to ischemia by making someone's
clogged coronary arteries even more
narrow.
Carney and others have embarked on an
experiment to confirm the ischemia hypoth
esis. Depressed and nondepressed CAD pa
tients will undergo a stress test. Each group
will have the same degree of measurable
blockage in their coronary arteries. If
Carney's hypothesis holds up, depressed
CAD patients will experience ischemia be
fore the nondepressed CAD patients, and
perhaps more severely.
The results of Carney's and Lustman's
experiments should add further twists and
turns to medical thought on the mind-body
connection .
The New Age movement and holistic
medicine have pushed the mind-body link
to an optimistic extreme. Physically ill pa
tients aren't panned as their own worst ene
mies, but praised as divinities in disguise.
Tap your divinity ... think positive, relax
ing thoughts ... and you can heal yourself.
The headline for a recent cover story of
Omni magazine announces, "Mind Exer
cises That Boost Your Immune System."
The story includes a testimony of a woman
who said she triumphed over lympathic
cancer by imagining a war between her
tumor and chemotherapy drugs. The latter
won by vaporizing "the cancer-causing
warriors."
Medical researchers, however, are still
waiting for double-blind studies to back up
the claims.
don't think you can imagine your
cancer away;' says Barry A. Hong,
Ph.D., an assistant professor of
medical psychology in psychiatry, who is
delving into the emotional patterns of AIDS
and other chronically ill patients.
Mind-over-matter proponents operate "in
a religious rather than scientific fashion;'
adds Carney. "They aren't playing the same
game ."
Clouse says he and his colleagues are
avoiding the pursuit of some comprehensive
theory explaining how the mind and body
interact. Rather, their research attempts to
accurately describe the symptoms and clini
cal expressions of physical diseases that
may be psychosomatic. Even though they
may not initially understand the pathology,
they may discover treatments.
"If we waited for an understanding of
pathology, these people would never be
treated;' Clouse says. "The pathology of de

pression wasn't known when antidepres
sants were developed. That happened by
chance."
Unlike diseases such as cancer, depres
sion and other psychiatric disorders can't be
scrutinized under a microscope. Clouse
welcomes diagnostic help from positron
emission tomography, or PET. Researchers
at the School of Medicine, where the tech
nology was developed in the early 1970s,
have used PET to pinpoint centers in the
brain responsible for thinking and anxiety.
Advances in medical technology have
subjected patients' psyches to new chal
lenges, says Hong. Chronic illnesses such
as AIDS can be detected long before the pa
tient experiences any symptoms. The result
is what Hong calls the Damocles dilemma,
named after the Sicilian of antiquity who
sat down at a luxurious banquet only to see
a sword suspended by a hair above his
head.
"The person who knows he has a chronic
illness has two choices-he can go on with
life-enjoy the banquet-or he can worry
about the sword over his head," says Hong.
You don't have to believe that some dis
eases start in your head to get the point. A
patient's emotional state always merits at
tention, whether or not it's physiologically
related to his illness. Speaking about AIDS
patients, Hong sums up this viewpoint well.
"We may not eradicate the virus. Our job
will be to help people live more effectively
despite their illness."
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Tricking The Sindbis Virus
Into Productivity
by Steve Kohler

Medical science takes its allies wherever it can find or create them, sometimes even from among an
unlikely group such as the vi1l.lses. Parasitic and self-serving, viruses are nothing more than bits of
genetic infomlation wmpped in tiny protein shells, existing solely to produce more infectious particles
just like themselves at the expense of the cells they intect. Their efficiency makes them powerful
agents of disease. But viruses can't think. And clever molecular microbiologists are tricking them into
working hard for the purposes of science.

19

Fooling the virus
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virus subverts the cell it in
vades. We subvert the virus :'
says Henry V. Huang, Ph .D . ,
in explaining how he and his
co-investigators at the School of Medicine
have engineered one particular virus to be
newly useful.
Using what Huang calls "conventional
cut-and-paste techniques;' the researchers
enter the genetic component of the common
Sindbis virus and delete some of the infor
mation there. In its place, they splice a new
set of genetic instructions for the product
they seek. When the altered viral agent is
applied to host ceJls, it infects them and all
but "sucks them dry" in its work, says
Huang, an assistant professor of micro
biology and immunology. Instead of mak
ing more virus particles, however, it is
fooled into manufacturing the protein dic
tated by the new genetic directions.
Why are such products valuable? The
purpose of most of the approximately
100,000 human genes is to carry the bio
chemical instructions for the manufacture of
a single protein. Life depends on those pro
teins for its form and the regulation of its
systems .
So proteins made in this way can be of
great value in the research lab , where the
supply for study has been insufficient and
time-consuming to produce.
They can be of immense clinical signifi
cance, too . The lymphokines that allow the
parts of the immune system to communi
cate, clotting agents , growth hormones and
tissue plasminogen activators that are so
vital to medicine-all are proteins manufac
tured by the body under the if!structions of
specific genes.
In industry, proteins are no less impor
tant. For example, one kind of protein
the enzymes-converts com to the high
fructose sweetener used in many food
products. Gene expression using vectors, or
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carriers, like the Sindbis virus make it
possible to generate large quantities of such
products.
Commenting on the impact of the work
by the Washington University researchers,
Richard Mulligan, an associate professor of
molecular biology at MIT, says: "They've
harnessed the unique properties of the virus
to make large quantities of proteins, many
of which should be applicable for both
basic studies and clinical procedures:'
Some limitations remain. "The Sindbis
virus might refuse to express certain pro
teins;' cautions team member Charles M.
Rice, Ph .D., but early tests with just two
are encouraging. And the investigators have
shown that there is space available on the
Sindbis virus' genetic molecule to accom
modate most genes specific for protein
production.
The Sindbis virus itself is not a new dis
covery. It has been known since 1952 and is
common in Europe, Asia, Africa and Aus
tralia; it is transmitted by mosquitoes. Rela
tively benign for humans, a Sindbis virus
infection may produce a stiff neck and little
more .
Unlike viruses previously employed in
the engineering of proteins , however, Sind
bis is an RNA virus. Its genetic instructions
reside along a single strand of coiled ribo
nucleic acid rather than in the more com

monly known double helix of deoxyribonu
cleic acid, or DNA. It does not go through
a DNA stage as retroviruses do . Before the
team can manipulate the virus ' genetic in
formation, Huang must make a DNA clone
of the purified single-strand RNA . "All the
tools for this work have been developed
for DNA, not RNA;' explains Sondra
Schlesinger, Ph.D. , a professor of micro
biology and immunology and a member of
the research tearn .
During that additional, intermediate step,
the scientists make their changes. What
Huang calls cut-and-paste technology is ac
tually a process that begins with snipping
the genetic molecule into smaller sections.
Certain enzymes act to cleave the DNA
only at particular junctions of the elements
that form the long strand characteristic of
genetic molecules . Those enzymes are the
"scissors" that do the biochemical snipping.
All of the genes along the length of the
Sindbis virus ' genome, the narne given to
the complete set of genetic instructions,
have been mapped . One sector carries in
structions on how the virus will replicate it
self. That portion , Huang does not disturb.

Huang and his fellow researchers re11UJve
the protein coat from the Sindhis virus
and lake out its RNA (1). This RNA is
copied into double-stranded DNA and
cloned (2). Then they cut the DNA and
take out the portion that encodes for the
virus' protein coat, replacing it with the
gene for the desired protein (3). The 11UJdi
jied DNA clone is used to produce a 11UJdi
jied RNA. When this 11UJdified RNA is
introduced to a cell, it replicates and
produces a smaller RNA that is read by
ribosomes and used to manufacture the
desired protein instead of the virus'
protein coat (4).
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Another section contains the rules for
building the three structural proteins that
package the genome into new viral parti
cles, or virions. To that part , Huang applies
the enzyme technology that snips off the
genes. In place of the originals, he sup
plants the gene that carries the instructions
for the protein he wants to produce.
Identical RNA molecules are then tran
scribed from the "master copy" and saved
for future production. The RNA is infec
tious and can be applied directly to host
cells, a process called "transfection ."
The techniques of producing such altered
Sindbis RNA and collecting the product of
the infected cells take about three days .
Manipulations are fast enough that many
clones can be tested simultaneously. Each
may contain instructions for a different pro
tein, or they can represent mutations of the
same protein, a potential windfall for re
searchers who study the variants for their
changes in function, stability or shape.
Previously, engineering a virus to pro
duce experimental proteins required a mini
mum of two weeks, often much longer.
"You can see;' Huang says, "that you're
more likely to do the work if it takes only

three days rather than two weeks . And
investigations can proceed much more
rapidly."
Another advantage of an RNA virus as a
vector is its relatively simple replication
scheme. The processes it incites take place
in the cytoplasm surrounding the host cell's
nucleus rather than deep within the nucleus
itself. The number of biochemical steps re
quired for the production of the protein is
thereby reduced , says Rice .
And Sindbis is a small virus, with a
short and manageable set of genetic instruc
tions. The longer the genome, the more
difficult it is to manage, Huang explains .
In extreme cases, even the most precise
enzyme may cleave a molecule in so many
places that manipulating a particular sec
tion is impossible. Researchers exploring
large viruses with long genomes have had
to resort to a cumbersome recombination
technique.
In that approach , the gene for the protein
desired is added to a host cell before infec
tion with the virus. Via a process called
"crossing over;' a small fraction of the vi
rions that result from the infection will
carry the critical gene, but scientists must

still identify, purify and grow those mu
tants . Huang calls that process "highly
inefficient."
Sindbis also promises to surpass other
viral vectors in its production capacity. In
a paper published in the March 3, 1989,
edition of Science, Huang and his co
investigators report that their viral agent
produced 108 (or 100 million) molecules of
protein per infected cell in 16 to 20 hours.
That is roughly equal to the amount of pro
tein the virus would have produced to pack
age new particles, had its instructions not
been changed, Schlesinger notes.
Because of the speed with which gene
products can be expressed by Sindbis, it
may turn out to be particularly useful for
generating unstable proteins - those that
enzymes break down quickly, resulting in
lower yields.
The quantity approaches that of bac
ulovirus-one of the most prolific of all
known viruses-that expresses up to 1010
molecules of protein per host cell. Unfortu
nately, baculovirus will only grow on moth
cells . And the protein produced in insect
cells is largely inappropriate for human
applications, since it does not contain a
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When Sindbis virus infects tire cell (1), it replicates its RNA
(2). It also produces a smaller RNA (3) tlrat is read by ribo
somes and used to 11Ulnufacture large tml()unts of coat pro
tein. I111! coat protein packages tlte viml RNA (4) to produce
new virus particles (5) .
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Genetically altered RNA (1) lacks the ability to produce coat proteins, but if research
ers supply the coat proteins (2), the virus can assemble into numerous infectious par
ticles (3). Each ofthese infectious particles can be used to infect new cells (4), pro
ducing large amounts of the desired protein (5). Having no source of coat proteins,
no infectiolls virus can be produced.

fundamental sialic acid group; in human
metabolism , the liver quickly removes all
proteins that do not display that acid group
as a sort of flag for freshness.
The production of experimental proteins
by means of a bacterial vector cannot com
pete with the Sindbis virus, either. The
well-known E . coli bacteria grows at high
rates, but proteins synthesized in that way
often lack what are essential modifications,
such as carbohydrate molecules. To clin
ically employ proteins expressed in E. coli
would require extra, difficult biochemical
processes that would adversely affect
yields.
One of the Sindbis virus' most endearing
qualities-the exception that proves the rule
about all viruses being eminently unlikable
-is its broad host range . Huang's team,
in research supported by grants from the
National Institutes of Health, the Pew
Memorial Trust Fund and the Monsanto/
Washington University Research Contract,
has shown that the Sindbis vector operates
efficiently in cultured cells from mammals,
birds and some insects .
The Science paper reports on studies in
which the scientists altered Sindbis to ex
press the protein chloramphenicol acetyl
transferase (CAT). The cells of chicken
embryos were used as a host. CAT is not of
particular importance outside the lab , but

it is readily identifiable, and the amounts
made are particularly easy to measure.
Control vectors of uninfected cells and cells
infected with unaltered virus produced es
sentially no CAT. "There is no endogenous
activity like it; ' says Huang. "The controls
are very simple and very clean ."
Though this vector represents a powerful
new research tool, the investigators still
confront a bottleneck: The scientists are not
nearly as productive as the virus. Transfect
ing cells with altered RNA has been ex
perimentally effective, but it is inefficient
on any real-world scale. "If we throw in ten
million molecules of RNA, we may hit one
cell," says Huang. "On a good day, we can
transfect only about ten thousand cells."
And that's not enough to manufacture com
mercially practical quantities of protein .
Seeking an increase in their efficiency by
several orders of magnitude, team members
have turned back to the virus. By adding a
"helper" virus to provide the structural pro
teins , they again make possible the produc
tion of infectious virions carrying their new
genetic information . Those virus particles
will infect every susceptible cell to which
they are introduced, so the success rate
jumps from one in each 10,000,000 tries to
a perfect one for one. Efficient packaging
has been clearly demonstrated as a
possibility.
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But the elegance of the system is largely
lost in that demonstration because the
helper virus restores the missing RNA code
for packaging. Therefore, the virions con
tinue to spawn infectious generations. The
Washington University team would most
like to have the power of the virus com
bined with the safety of a "suicide" vector
that dead-ends once host cells are infected .
They want to keep the punchline to this
most practical of jokes they play.
Toward that goal, the scientists hope to
be able to make available only the virus'
packaging materials-the structural proteins
in a line of host cells. Such cells, when
transfected, would yield one generation of
highly infectious particles. The particles
would carry the altered RNA instructions to
produce the protein desired, but no genetic
instructions for making more packages.
During the final stage of production in plain
cells , the infectious elements would be
trapped in the depleted host, unable to
make shells in which to escape. As Huang
puts it, in this scheme "the vector system is
one-way."
That can be an indispensable feature. "If
you're making human growth hormone, for
example, the last thing you want around is a
lot of virus," says Huang. And he includes
even the friendliest , most easily duped
variety.
23

}bu'reDeaf:
The hazards of recreational noise

24

he federal government and private
industries have gone to great
lengths to protect the hearing of
people in the workplace, yet myr
iad studies by Washington University re
searcher William Clark, Ph.D., indicate
that workers of all types may be in more
danger of losing their hearing off the job .
According to one of his more recent
studies, which surveyed and evaluated the
hearing of 413 workers at a major chemical,
textile and pharmaceutical company with an
effective hearing conservation program ,
recreational hunting and target shooting
pose a greater risk to hearing than industrial
noise. "The bottom line is that the people
who worked in the noisy plant but didn't
shoot had better hearing than the people
who worked in the quiet office and did
shoot;' says Clark, an associate research
scientist at the Central Institute for the
Deaf. "It wasn't what they were doing on
the job, but what they were doing off the
job that caused the most hearing loss."
Clark's study, which was published in
last summer's issue of Hearing Conserva
tion News , tested the hearing levels of two
groups of employees: office workers who
were exposed to very little occupational
noise and plant workers who were exposed
to a lot of it.
All employees were asked if they had en
gaged in hunting or target shooting, and if
they had any prior military service. A "yes"
to any of these questions categorized them
as a shooter.
The results of the tests showed that plant
workers typically had hearing levels that
were 5 decibels worse than the office
workers, but that the hearing of shooters
was about 15 decibels worse than that of
non-shooters, Clark says. That is, the aver
age difference in hearing sensitivity be
tween shooters and non-shooters was twice
as much as the difference between plant and
office workers .
It's true that industrial noise can cause
hearing loss, Clark says, but it's not the
only cause. "There's a whole world of noise
exposure that's present in the environment
whether you're driving to work on a noisy
freeway, running a chainsaw on the week
end, going to a noisy discotheque or wear
ing a Sony WaLkman;' he says. "While
some of the federal laws we have are de
signed to protect the worker from excessive
exposure to noise in the workplace, there
are no laws that control the amount of noise
he receives when he goes home." To make
matters worse, studies of hearing in indus
trial popUlations indicate that people who
work in noise tend to play in noise, that is,
blue collar workers engage in noisy, non-
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William Clark, Ph,D. , measures noise levels aJ 64 West, a popular St. Louis night spot.
occupational activities like hunting , use
of power tools and motorcycle riding more
frequently than white collar workers. "So
unless you protect the individual from all
noise-not just occupational noise-you 're
not going to protect the hearing of individu
als;' he says .
As Clark points out, shooting and other
sources of recreational noise often exceed
levels that would be considered a violation
in an industrial setting.
This is a concern that he and his col
league Barbara Bohne, Ph.D., professor of
otolaryngology, have voiced frequently.
Their analysis of noise exposures at a
Bruce Springsteen concert , reported in the
Journal of the Acoustical Society of Amer
ica, measured an average level of more than
100 decibels-a violation of the federal
workplace law and enough noise to produce
a temporary hearing loss in nearly anyone.
Ballparks are another arena where recre
ational noise levels can exceed federal
workplace standards . During the 1987
World Series, Clark-and Minnesota
experts-measured noise levels at the
Hubert H. Humphrey Metrodome in

Minneapolis and deternuned that they
approached and at times exceeded federal
workplace standards. That was enough to
send most people, including Clark, home
with a 20 to 25 decibel temporary hearing
loss.
Exposures that cause temporary changes
in hearing can and do cause permanent
damage to the tissues of the inner ear, Clark
explains. Sensory cells are killed by exces
sive noise exposure and replaced by scar
tissue.
And while 30 percent to 50 percent of
these cells can be killed before there's a de
tectable change in hearing sensitivity, it is
important for people to realize early that
even though they may think their hearing
has returned to normal, their sensory cells
have sustained permanent damage , and
some of them have been killed.
Whether it be from overexposure at
work , shooting, rock concerts, high noise
levels at the ballpark or symphony-sym
phony concerts can reach highs of 105 deci
bels-the cumulative effect is that 20 per
cent to 25 percent of people in the United
States will experience enough hearing loss
25

that they have difficulty hearing nonnal
speech under quiet cond itions by the time
they tum 65. That needn ' t be the case .
Clark and Bohne 's studies with chinchil
las raised in a quiet environment indicate
that hearing loss is almost entirely due to
noise exposure, not to some intrinsic
change associated with age . Their results,
published as an abstract at the 1989 mid
winter meeting of the Association for Re
search in Otolaryngology, corroborate ear
lier studies of hearing levels in isolated
tribal populations. In the 1960s , a study of
the Mabaan tribe in the Sudan that com
pared older and younger tribe members
found identical hearing sensitivities . A
more recent study among natives of Easter
Island showed that living in civilized soci
ety has had a significant negative effect on
hearing. "It's tempting to conclude that hu
mans - if they could just stay away from
noise exposure-would have perfectly nor
ma] hearing when they're 65:' Clark says.
Yet he still hears reports about high
school dances where the loudspeakers pro
duce noise levels of 115 to 120 decibels ,
and people at discotheques who leave with
their ears ringing for days. " All these expo
sures count;' Clark says. " You have to ask
yourself, ' Why do people do that? " ,
Clark guesses it has to do with the fact
that high levels of noise cause increases in
adrenalin flow and heart rate . "Noise is ex
citing;' he says. He also suspects that some
people may seek out places such as noisy
bars because they can pursue social be
haviors that would be considered taboo out
side loud environments. People would not
nonnally approach complete strangers, lean
on their shoulders and talk into their ears ,
he explains . But in a noisy bar it becomes
acceptable , because people cannot hear one
another unless they move closer together.
Hearing conservation programs in in
dustry do their share of protecting people's
hearing, Clark believes. But if people are
really to protect themselves from hearing
loss, they must limit their exposure to noise
off the job.
Piano tuners, he's learned, do a great job
of that. Last summer he tested the hearing
levels of approximately 150 piano tuners
who were attending a Piano Technicians
Guild meeting in St. Louis . As a whole, the
group had better hearing than industrial
workers, the average man on the street and
the highest international standard. 'They
had hearing levels that were even better than
the best; ' Clark says.
But then only 20 percent reported having
noisy hobbies. The piano tuners are an ex
ception, however. In other industries Clark
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has studied, about two-thirds of the workers
report noisy hobbies. It makes sense, con
sidering that piano tuners make their living
from their hearing, Clark says. "One guy
said he even wears earplugs while driving
his car."
Clark does not suggest people go to that
extreme , but he does promote a reasonable
sense of precaution. " It's the total dose of
noise you get in your lifetime that 's impor
tant;' he says . "If you work in a quiet en
vironment you don't need to be quite as
concerned as someone who works in a
noisy foundry or automobile factory."
There are no laws that protect the hearing
of people engaged in recreational activities,
Clark says, nor should there be. "It 's one of
those cases of caveat emptor, let the buyer
beware;' he comments.

People should avoid excessive noise
when they can and wear ear protectors
while using firearms and handling noisy
machinery. Clark forestalls a common com
plaint of hunters-that they can ' t hear their
prey when wearing ear protectors-by ad
vising them to look for newly available pro
tectors that not only protect the ears from
high levels of noise, but also amplify the
low level noises typically made by animals
in the woods .
The ear responds to noise in much the
same way that skin responds to the sun,
Clark adds. "We know that excessive expo
sure to sunlight can cause skin cancer, but
that doesn't mean we should stay in the
dark all the time. We just need to avoid too
much sun and use sunscreen when we ' re
out."
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Alumni Achievement AHKll-ds:
Richard David Aach,
M.D. '59, is physician-in
chief and head of the depart
ment of medicine at Sinai
Hospital of Baltimore and pro
fessor of medicine at Johns
Hopkins University. He has
distinguished himself through
his viral hepatitis research, and
his blood bank screening meth
ods for non-A non-B hepatitis
are used throughout the world .
Since his days as chief resident
at Barnes (1964 to 1965), he
has been a pioneer and leader
in shaping internal medicine
house staff training programs
in the U.S. He is considered to
be a leading national advocate
for interns and residents in
internal medicine .

Charles Eckert, M.D. '39,
distinguished professor emeri
tus of surgery at Albany
Medical College of Union
University, began his cele
brated career at Washington
University. He served on the
surgical faculty from 1944 to
1956 and then as professor of
surgery and chainnan of the
department of surgery at Al
bany. He has held leadership
positions with the nation's
leading surgical societies. His
voluminous list of publications
includes the book "Emergency
Room Care;' first published in
1967 and still available in a
subsequent edition.

Jonathan Mann, M.D.
'74, director of the Global
Programme on AIDS for the
World Health Organization,
based in Geneva, previously
served as state epidemiologist
and chief medical officer for
the State of New Mexico and
deputy director of the State
Health Department. In 1984 he
became assistant to the director
of the Centers for Disease
Control's AIDS Program, with
responsibility for international
28

Award winners (left to right): Drs. Aff-Drum, King, Eckert, Berg, Karl, Shank and Aach (Mann
not shown).
programs. He established and
directed the Zaire AIDS Re
search Project (Project SIDA) ,
a collaborative Zairian, Bel
gian, American project
encompassing epidemiological,
laboratory, immunological and
clinical research.

and Aging Project, a long-tenn
study of intellectual function in
people aged 65 and older. Berg
serves on both the national and
St. Louis-chapter advisory
boards of the Alzheimer's Dis
ease and Related Disorders
Association . He became a
professor in 1972.

Alumni Faculty Awards:

Robert Ely Shank, M.D.
'39, is Danforth Professor

Helen Aff-Drum, M.D.
'34, works part time in the
community health departments
of St. Louis and Lincoln coun
ties. She worked in private
practice from 1938 to 1964.
She then worked for the Labor
Health Institute, Children's
Hospital, the St. Louis County
Children's Tuberculosis Clinic ,
and county health clinics in
neighboring Valley Park, War
ren County and Troy. She was
program manager of disease
prevention services (especially
TB) in St. Louis County,
served two tenns as president
of the American Lung Asso
ciation of Eastern Missouri
and directed the St. Louis
County Children's Chest
Clinic. She is associate profes
sor emeritus of clinical pediat
rics at Washington University.

Leonard Berg, M.D. '49,
is director of the medical
school's Alzheimer's Disease
Research Center, one of only
10 centers in the U.S . funded
by the National Institute on
Aging to study the disease . He
also is program director of the
School of Medicine's Memory

Emeritus of Preventive Medi
cine and retired head of the
medical school's department
of preventive medicine . His
lifelong commitment to nutri
tion has taken him all over the
world . After joining the faculty
in 1948 , he also became a nu
trition consultant to the U.S.
govenunent through its Public
Health Service, National Insti
tutes of Health, Office of the
Surgeon General, Department
of Agriculture , Indian Health
Service, Interdepartmental
Committee on Nutrition for
National Defense, Department
of State and President's Sci
ence Advisory Committee. He
also has served on the National
Research Council.

Distinguished Service
Awards:
"Michael Karl (M.D.) is a
doctor's doctor." That, accord
ing to one colleague, is the
highest compliment that can
be bestowed upon a physician .
Karl is presently the director of
clinical affairs in the School of
Medicine 's Department of
Medicine. In his research field,

hepatology, Karl 's studies have
been published frequently in
medical journals. He chaired
the Committee on Services to
the Elderly for the National
Council of Jewish Federations
from 1976 to 1981 and was ap
pointed to the White House
Conference on Families from
1978 to 1980. In St. Louis , he
co-organized the Jeff-Vander
Lou Medical Clinic for indi
gents from 1967 to 1972 and
served on the Municipal Nurs
ing Board in the early '60s.

M. Kenton King, M.D.,
joined the School of Medicine
faculty in 1957 as instructor in
medicine and preventive medi
cine and achieved the rank of
professor 10 years later. He
also was physician in charge of
Student Health Services at the
Medical Center from 1957 to
1962. Simultaneously, in 1960
and 1961, he was acti ng head
of the medical school 's Depart
ment of Microbiology and, in
1961 and 1962, assistant dean
of the medical school. King
was promoted to associate dean
in 1962 and dean in 1965. Ac
cording to Chancellor William
H. Danforth, "Dr. King has
guided the school through tre- .
mendous growth both in its
national stature and its physi
cal plant. Thanks in part to
Dr. King's exceUent leader
ship, this school is poised to
further establish itself as a pre
eminent world-class biomedi
cal research and training
institution." •

The class of 1949 organizes for a
class photograph .
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The newest alumni from the class of
1989, Ferdinand Salvacion, M.D.
(left) and Melvin Thornton, M .D.,
and guest Rose Siggs, enjoy the
banquet.
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Arnold Welch, M.D. '39 (left) and Bart
Passanante, M.D. '39, remember
when . ..

•

•

•

•

Bruce Broudy, M.D. (left) and
Thomas Osteen, M.D., check
reunion plans for the class of 1974.

The class of1924's 65th reunion: Milo Tedstrom, M.D.
(standing left) and Edward Halley, M.D. (right), both
from California, and George Garrison, M.D., from
Oklahoma.
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Clifford Talbertlr., M.D. '59, and classmates.
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Ron Evens, M.D. '64 (left) presents Dean M. Kenton King, M.D.,
with his distinguished service award.
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Members of the 50th reunion class (1939) receive
lifetime membership awards to the alumni
association.
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•
Chuck Norland, M.D. '59, and his wife, Ingrid, at
their class dinner.
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Members of the class of 1969 (left to right)
Drs. Richard Myaft, Barry Siegel and Robert
Kolodny share a story at their class dinner.

•

Incoming Alumni President Roger Mell, M.D. '65
(kft) accepts the gavel from Ron Evens, M.D. '64 .

•

•
James Owell, M.D. (kft) and
Robert Rosenberg, M.D., discuss the future ofrhe newest
member of the medical class of2015 at tile class of 1979 dinner.
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Steve Teitelbaum, M.D. '64, and Paul
Manske, M.D. '64 .
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Irvin Kushner, M .D. '54 (left) and his wife, Enid, enjoy the
chancellor's aluml/; recognition breakfast with Julia" C .
Skeper, M.D. '54.

•

The "Hot Docs" perfonn at the
reunion banquet.
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Vice Chancellorfor MedicaL Affairs
William A. Peck, M.D. (center)
greets frieTlds Richard Aach, M.D.
'59, and Janet Aach .

•

•
Alumni scientific faculty (left to right) CaroLyn
Robinowitz, M .D . '64; !.Ronan! Berg, M .D. '49;
Virgil Loeb Sr. , M.D . '44; Garrison Fatlunan,
M.D. '69; and program cizaintlatl Steve
Teitelballm, M.D. '64.

CharLie Ruggieri (seated), the ''father'' of Phi Beta
Pi, is greeted at the banquet.
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Melvin Goldman, M.D. '43M (left)
presents Chancellor William H.
Danforth, M.D. , with a gift for the
medical archives.

•

Mrs. John Bowers and Mrs . William H. Danforth
applaud award winners.
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•

•
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Father and son Guerdan Hardy, M.D. '29, and
David Hardy, M .D. '64, cekbrate their 60th and
25th reunions.

•
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•
David Globus, M.D. '54 (left) and Edwin Carter,
M .D. '54, at the dea/I's luncheun.

•
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Enjoying the view from the Marriott Hotel, where
the banquet was held.
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Jean Rogier, M.D. (left) and Paul Hagemann,
M.D. , both from tile class of 1934.
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•

•

Sunny McCown picks out the young Allan
McCown, M.D. '64, from an oldfreshman class
picture.

Nonnan Arneson, M.D. '28 (left) congratulates
Mike Karl, M.D., on his distinguished sen>ice
award.

•

•
Nomzan Leffler, M.D. (right)
shares photos with M.D. '54 classmates
Richard Harte, M.D. (center) and Cooper Ray, M.D .

•
Donald Opila, M.D . ' 79, and his
wife, Mary, dance "with baby."
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Asa Jones, M .D. '42 (left) and Milo Tedstrom, M.D. '24, at the
dean's luncheon .
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Micluud Carpenter (right) helps Ricluud Paul with his hood prior to this
year's graduation ceremony on Hilltop Campus.

